Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard LeLacheur

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioanalysis|November 20, 2012
Recommendations on biomarker bioanalytical method validation by GCCRichard Hougton, Dominique Gouty, John Allinson, et al.
The AAPS Journal|June 26, 2014
Small molecule specific run acceptance, specific assay operation, and chromatographic run quality assessment: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teamsEric J Woolf, Stuart McDougall, Douglas M Fast, et al.
Bioanalysis|November 19, 2010
Formation of a Global Contract Research Organization Council for BioanalysisNoel Premkumar, Stephen Lowes, James Jersey, et al.
Bioanalysis|November 12, 2014
Recommendations on incurred sample stability (ISS) by GCCSteve Lowes, Richard LeLacheur, Ronald Shoup, et al.
Bioanalysis|November 22, 2014
7th GCC Insights: incurred samples use; fit-for-purpose validation, solution stability, electronic laboratory notebook and hyperlipidemic matrix testingMario Rocci, Steve Lowes, Ronald Shoup, et al.
Bioanalysis|October 24, 2012
Conference report: 6th GCC focus on LBA: critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilarsRobert Nicholson, Steve Lowes, Maria Cruz Caturla, et al.
Bioanalysis|February 27, 2016
9th GCC closed forum: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooksRoger Hayes, Richard LeLacheur, Isabelle Dumont, et al.
Bioanalysis|December 16, 2014
8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validationJoseph Bower, Douglas Fast, Fabio Garofolo, et al.
Bioanalysis|September 28, 2012
Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC)Steve Lowes, Mark Boterman, Mira Doig, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioanalysis|November 20, 2012
Recommendations on biomarker bioanalytical method validation by GCCRichard Hougton, Dominique Gouty, John Allinson, et al.
The AAPS Journal|June 26, 2014
Small molecule specific run acceptance, specific assay operation, and chromatographic run quality assessment: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teamsEric J Woolf, Stuart McDougall, Douglas M Fast, et al.
Bioanalysis|November 19, 2010
Formation of a Global Contract Research Organization Council for BioanalysisNoel Premkumar, Stephen Lowes, James Jersey, et al.
Bioanalysis|November 12, 2014
Recommendations on incurred sample stability (ISS) by GCCSteve Lowes, Richard LeLacheur, Ronald Shoup, et al.
Bioanalysis|November 22, 2014
7th GCC Insights: incurred samples use; fit-for-purpose validation, solution stability, electronic laboratory notebook and hyperlipidemic matrix testingMario Rocci, Steve Lowes, Ronald Shoup, et al.
Bioanalysis|October 24, 2012
Conference report: 6th GCC focus on LBA: critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilarsRobert Nicholson, Steve Lowes, Maria Cruz Caturla, et al.
Bioanalysis|February 27, 2016
9th GCC closed forum: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooksRoger Hayes, Richard LeLacheur, Isabelle Dumont, et al.
Bioanalysis|December 16, 2014
8th GCC: consolidated feedback to US FDA on the 2013 draft FDA guidance on bioanalytical method validationJoseph Bower, Douglas Fast, Fabio Garofolo, et al.
Bioanalysis|September 28, 2012
Recommendations on bioanalytical method stability implications of co-administered and co-formulated drugs by Global CRO Council for Bioanalysis (GCC)Steve Lowes, Mark Boterman, Mira Doig, et al.
Pageof 1